Regeneron Pharmaceuticals’ investigational melanoma combination therapy shows continued response after two years in a Phase I ...

What could a tree possibly reveal about the European Society for Medical Oncology (ESMO)? Quite a lot, says Prof Andres Cervantes, Professor of Medicine at the University of Valencia, Spain ...

Targeted therapy has seen a threefold increase in the 12-month progression free survival (PFS) rate versus standard of care ...

The following abstracts showcase the top cutting-edge research presented at the European Society for Medical Oncology (ESMO) ...

Susanne Bobadilla from VML Health, joined by a team of 15 medical, digital strategists and client engagement experts from across the company, looks at the top trends coming out of ESMO 2024 and what ...

本文仅供中国大陆地区执业的医学药学专业人士参考，如您非前述专业人士，请离开本页面胃癌是全球范围内常见的恶性肿瘤之一，据统计，2022 年全球胃癌新发病例约 96.8 万，死亡病例约 66 ...

9月13-17日，2024年欧洲肿瘤内科学会（ESMO）大会在西班牙巴塞罗那盛大召开。作为肿瘤领域最具权威的年度盛会之一，ESMO大会涵盖了基础研究、转化 ...

Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from the sovleplenib ESLIM-01 Phase III trial, as well as several investigator-initiated studies of compounds ...

编者按： 2024年欧洲肿瘤内科学会亚洲年会（ESMO ASIA 2024）将于当地时间12月6日～8日在新加坡召开，将展示和讨论亚洲及全球肿瘤学领域的最新科学和临床研究，这些进展将进一步推动年末的学术交流热潮！近日ESMO ...

esmo group has launched its latest product—the Apollo Quad Handler. Designed to bridge the gap between the engineering and ...

2024年欧洲肿瘤内科学会亚洲年会（ESMO Asia Congress 2024）将于当地时间12月6日~8日在新加坡召开。ESMO ...